-
1.发明申请公开(公告)号：US20190262329A1
公开(公告)日：2019-08-29
申请号：US16406918
申请日：2019-05-08
Applicant: Boehringer Ingelheim Vetmedica GmbH
Inventor： Balazs ALBRECHT , Michael AVEN , Janine LAMAR
Abstract: The disclosure relates to the field of medicine, in particular to the field of veterinary medicine. The disclosure specifically relates to muscarinic antagonists (including long acting muscarinic antagonists (LAMAs)) for the treatment of airway disease, such as pulmonary disease, preferably recurrent airway obstruction (RAO), summer pasture associated obstructive pulmonary disease (SPAOPD), and inflammatory airway disease (IAD) in animals, preferably equines such as horses.
-
2.发明申请公开(公告)号：US20180339054A1
公开(公告)日：2018-11-29
申请号：US16047313
申请日：2018-07-27
Applicant: Boehringer Ingelheim Vetmedica GmbH
Inventor： Michael AVEN , Tim LUKAS
IPC: A61K47/40 , A61K47/69 , A61K9/08 , A61K31/501 , A61K9/00
Abstract: A preserved liquid aqueous pharmaceutical composition includes one or more etherified cyclodextrin derivatives, at least one water-soluble preservative, and at least one pharmaceutically active compound which is poorly water-soluble, very poorly water-soluble or water-insoluble. The liquid aqueous pharmaceutical composition provides an acceptable solubility of the pharmaceutically active compound, such as pimobendan, in aqueous solution whereby the water-soluble preservatives retain their effectiveness in the presence of the etherified cyclodextrin derivatives allowing the use in an oral administration form.
-
公开(公告)号：US20170368274A1
公开(公告)日：2017-12-28
申请号：US15528260
申请日：2015-11-19
Applicant: Boehringer Ingelheim Vetmedica GmbH
Inventor： Holger REINECKE , Benjamin FRANZMANN , Marcus Rainer RAHMEL , Michael AVEN , Steffen SCHUY , Andree JUNG
CPC classification number: A61M15/009 , A61D7/04 , A61M11/008 , A61M11/02 , A61M15/0015 , A61M15/0035 , A61M15/0038 , A61M15/0086 , A61M15/08 , A61M2016/0024 , A61M2205/8281 , A61M2207/00 , A61M2250/00 , B05B11/0039 , B05B11/00412 , B05B11/00442 , B05B11/00446 , B05B11/0054
Abstract: A container for holding, dispensing and/or storing a preferably liquid medicament preparation is proposed, which comprises an inner space for the medicament preparation and an at least partially multi-layered wall structure defining the inner space, the wall structure comprising a first layer with a first through-opening of less than 40 μm. Alternatively or additionally, the wall structure comprises a second and third layer, a second through-opening being provided in the second layer and the third layer covering or closing off the wall structure.
-
4.发明申请公开(公告)号：US20150366855A1
公开(公告)日：2015-12-24
申请号：US14740582
申请日：2015-06-16
Applicant: Boehringer Ingelheim Vetmedica GmbH
Inventor： Balazs ALBRECHT , Michael AVEN , Janine LAMAR
CPC classification number: A61K31/46 , A61K9/0073 , A61K9/008 , A61K31/58 , A61K35/06 , A61K45/06 , A61M15/009 , A61M2250/00 , A61K2300/00
Abstract: The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention specifically relates to muscarinic antagonists (including long acting muscarinic antagonists (LAMAs)) for the treatment of airway disease, such as pulmonary disease, preferably recurrent airway obstruction (RAO), summer pasture associated obstructive pulmonary disease (SPAOPD), and inflammatory airway disease (IAD) in animals, preferably equines such as horses.
Abstract translation: 本发明涉及医学领域，特别涉及兽医领域。 本发明具体涉及毒蕈碱拮抗剂（包括长效毒蕈碱拮抗剂（LAMAs）），用于治疗气道疾病，例如肺部疾病，优选复发性气道阻塞（RAO），夏季牧场相关阻塞性肺病（SPAOPD）和炎性气道 动物中的疾病（IAD），优选马，如马。
-
公开(公告)号：US20180153907A1
公开(公告)日：2018-06-07
申请号：US15889307
申请日：2018-02-06
Applicant: Boehringer Ingelheim Vetmedica GmbH
Inventor： Balazs ALBRECHT , Michael AVEN , Janine LAMAR , Ingo LANG
CPC classification number: A61K31/58 , A61K9/0073 , A61K9/0078 , A61K9/008
Abstract: Methods of treating airway diseases in equines include administering to an equine an effective amount of ciclesonide or a pharmaceutically acceptable salt thereof or a composition including ciclesonide or a pharmaceutically acceptable salt thereof.
-
Patent Agency Ranking
公开(公告)号：US20150313918A1
公开(公告)日：2015-11-05
申请号：US14654009
申请日：2013-12-18
Applicant: BOEHRINGER INGELHEIM VETMEDICA GMBH
Inventor： Balazs ALBRECHT , Michael AVEN , Janine LAMAR , Ingo LANG
CPC classification number: A61K31/58 , A61K9/0073 , A61K9/0078 , A61K9/008
Abstract: The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention relates to glucocorticoids, especially ciclesonide or a pharmaceutically acceptable derivative thereof, for the treatment of airway disease in horses, such as pulmonary disease, preferably recurrent airway obstruction (RAO), Summer Pasture Associated Obstructive Pulmonary disease (SPAOPD), and inflammatory airway disease (IAD).
Abstract translation: 本发明涉及医学领域，特别涉及兽医领域。 本发明涉及用于治疗马中气道疾病的糖皮质激素，特别是环索奈德或其药学上可接受的衍生物，例如肺部疾病，优选复发性气道阻塞（RAO），夏季牧场相关阻塞性肺病（SPAOPD）和炎性气道 疾病（IAD）。
-
公开(公告)号：US20170079988A1
公开(公告)日：2017-03-23
申请号：US15292765
申请日：2016-10-13
Applicant: Boehringer Ingelheim Vetmedica GmbH
Inventor： Balazs ALBRECHT , Michael AVEN , Janine LAMAR , Ingo LANG
CPC classification number: A61K31/58 , A61K9/0073 , A61K9/0078 , A61K9/008
Abstract: The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention relates to glucocorticoids, especially ciclesonide or a pharmaceutically acceptable derivative or salt thereof, for the treatment of airway disease in horses, such as pulmonary disease, preferably recurrent airway obstruction (RAO), Summer Pasture Associated Obstructive Pulmonary disease (SPAOPD), and inflammatory airway disease (IAD).
-
8.发明申请MUSCARINIC ANTAGONISTS AND COMBINATIONS THEREOF FOR THE TREATMENT OF AIRWAY DISEASE IN HORSES 审中-公开用于治疗马齿苋病的麻醉药拮抗剂及其组合公开(公告)号：US20170007593A1
公开(公告)日：2017-01-12
申请号：US15274259
申请日：2016-09-23
Applicant: Boehringer Ingelheim Vetmedica GmbH
Inventor： Balazs ALBRECHT , Michael AVEN , Janine LAMAR
CPC classification number: A61K31/46 , A61K9/0073 , A61K9/008 , A61K31/58 , A61K35/06 , A61K45/06 , A61M15/009 , A61M2250/00 , A61K2300/00
Abstract: The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention specifically relates to muscarinic antagonists (including long acting muscarinic antagonists (LAMAs)) for the treatment of airway disease, such as pulmonary disease, preferably recurrent airway obstruction (RAO), summer pasture associated obstructive pulmonary disease (SPAOPD), and inflammatory airway disease (IAD) in animals, preferably equines such as horses.
Abstract translation: 本发明涉及医学领域，特别涉及兽医领域。 本发明具体涉及毒蕈碱拮抗剂（包括长效毒蕈碱拮抗剂（LAMAs）），用于治疗气道疾病，例如肺部疾病，优选复发性气道阻塞（RAO），夏季牧场相关阻塞性肺病（SPAOPD）和炎性气道 动物中的疾病（IAD），优选马，如马。
-
公开(公告)号：US20240024482A1
公开(公告)日：2024-01-25
申请号：US18481566
申请日：2023-10-05
Applicant: Boehringer Ingelheim Vetmedica GmbH
Inventor： Michael AVEN , Benjamin FRANZMANN , Matthias HAUSMANN
Abstract: The disclosure relates to the field of medicine, in particular to the field of veterinary medicine. The disclosure relates to a pharmaceutical (medicament) formulation of glucocorticoids, especially ciclesonide or a pharmaceutically acceptable derivative thereof.
-
公开(公告)号：US20210106685A1
公开(公告)日：2021-04-15
申请号：US17132038
申请日：2020-12-23
Applicant: Boehringer Ingelheim Vetmedica GmbH
Inventor： Michael AVEN , Balazs ALBRECHT , Benjamin FRANZMANN , Matthias HAUSMANN , Janine LAMAR , Ingo LANG
Abstract: The disclosure relates to the field of medicine, in particular to the field of veterinary medicine. The disclosure relates to a pharmaceutical (medicament) formulation of glucocorticoids, especially ciclesonide or a pharmaceutically acceptable derivative thereof.
-
-
-
-
-
-
-
-
-
Search Results
10
records
(took 0.018 seconds)
